Sanjeev Narula - Aug 12, 2024 Form 4 Insider Report for Intra-Cellular Therapies, Inc. (ITCI)

Role
Executive Vice President & CFO
Signature
/s/ John P. Condon, Attorney-in-fact
Stock symbol
ITCI
Transactions as of
Aug 12, 2024
Transactions value $
$0
Form type
4
Date filed
8/14/2024, 06:01 PM
Previous filing
Mar 6, 2023

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ITCI Stock Option (right to buy) Award $0 +17.3K $0.00 17.3K Aug 12, 2024 Common Stock 17.3K $74.90 Direct F1
transaction ITCI Restricted Stock Units Award $0 +35K $0.00 35K Aug 12, 2024 Common Stock 35K Direct F2, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The option vests as to one third of the shares on August 12, 2025, one third of the shares on August 12, 2026 and one third of the shares on August 12, 2027.
F2 Each restricted stock unit represents a contingent right to receive one share of common stock.
F3 The restricted stock units vest as to one third of the shares on August 12, 2025, one third of the shares on August 12, 2026 and one third of the shares on August 12, 2027.